Drug recall · October 13, 2021
Firvanq recall
Why: Product Mix-up: Incorrect diluent component included in the kit.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle containing 145 mL Grape Flavored Diluent for reconstitution per carton, Rx only, Manufactured for: Azurity pharmaceuticals, Wilmington, MA 01887, NDC 65628-206-05.
- Lots / codes
Lot # 21035, Exp 7/31/2022
- Quantity
- 2,751 kits
- Company
- Azurity Pharmaceuticals, Inc., Wilmington, MA
- Distribution
- USA nationwide
- Initiated
- August 24, 2021 · Voluntary: Firm initiated
- Classified
- October 5, 2021
- Reported
- October 13, 2021
- Ended
- May 12, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Firvanq
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.